Interestingly, it has been reported that the isoform-2 of PPAR-γ (PPAR-γ2) is implicated in metabolic alterations such as obesity, insulin resistance, type 2 diabetes, and dyslipidemia. Here, PPARG is linked to type 2 diabetes mellitus.